PMLive27m
Sanofi’s Qfitlia granted FDA approval to treat haemophilia A or B
Sanofi’s Qfitlia (fitusiran) has been approved by the US Food and Drug Administration (FDA) as the first therapy to treat ...
PharmiWeb1h
Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors
The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes ...
Expanding early type 1 diabetes risk detection using digital health
Take the type 1 diabetes (T1D) space, as one example. Today, new and exciting advancements are working to reduce barriers, ...
European Medical Journal2h
Sanofi’s chlamydia vaccine fast-tracked by FDA
This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.
Pharmabiz8h
US FDA approves Sanofi’s Qfitlia to treat haemophilia A or B, with or without factor inhibitors
Silver Spring, Maryland Monday, March 31, 2025, 09:00 Hrs [IST] ...
CWEB19h
Sanofi’s Qfitlia: A Breakthrough Hemophilia Therapy Approved by FDA
Introduction The U.S. Food and Drug Administration (FDA) has granted approval for Sanofi’s (NASDAQ:SNY) hemophilia therapy, Qfitlia, marking a significant advancement in treatment options for patients ...